Ben A Hickey1, Ultan Watson2, Andrew Cleves2, Raza Alikhan2, Neil Pugh2, Len Nokes3, Anthony Perera2. 1. University Hospital of Wales, Heath Park, Cardiff CF14 4XW, Wales, UK. Electronic address: drhickey@hotmail.co.uk. 2. University Hospital of Wales, Heath Park, Cardiff CF14 4XW, Wales, UK. 3. Cardiff University, Cardiff, Wales, UK.
Abstract
BACKGROUND: Our aim was to determine the evidence for thromboprophylaxis for prevention of symptomatic venous thromboembolism (VTE) in adults with foot or ankle trauma treated with below knee cast or splint. Our secondary aim was to report major bleeding events. METHODS: MEDLINE and EMBASE databases were searched for randomized controlled trials from inception to 1st June 2015. RESULTS: Seven studies were included. All focused on low molecular weight heparin (LMWH). None found a statistically significant symptomatic DVT reduction individually. At meta-analysis LMWH was protective against symptomatic DVT (OR 0.29, 95% CI 0.09-0.95). Symptomatic pulmonary embolism affected 3/692 (0.43%). None were fatal. 86 patients required LMWH thromboprophylaxis to prevent one symptomatic DVT event. The overall incidence of major bleeding was 1 in 886 (0.11%). CONCLUSIONS: Low molecular weight heparin reduces the incidence of symptomatic VTE in adult patients with foot or ankle trauma treated with below knee cast or splint. Crown
BACKGROUND: Our aim was to determine the evidence for thromboprophylaxis for prevention of symptomatic venous thromboembolism (VTE) in adults with foot or ankle trauma treated with below knee cast or splint. Our secondary aim was to report major bleeding events. METHODS: MEDLINE and EMBASE databases were searched for randomized controlled trials from inception to 1st June 2015. RESULTS: Seven studies were included. All focused on low molecular weight heparin (LMWH). None found a statistically significant symptomatic DVT reduction individually. At meta-analysis LMWH was protective against symptomatic DVT (OR 0.29, 95% CI 0.09-0.95). Symptomatic pulmonary embolism affected 3/692 (0.43%). None were fatal. 86 patients required LMWH thromboprophylaxis to prevent one symptomatic DVT event. The overall incidence of major bleeding was 1 in 886 (0.11%). CONCLUSIONS: Low molecular weight heparin reduces the incidence of symptomatic VTE in adult patients with foot or ankle trauma treated with below knee cast or splint. Crown
Authors: Abdullah Pandor; Daniel Horner; Sarah Davis; Steve Goodacre; John W Stevens; Mark Clowes; Beverley J Hunt; Tim Nokes; Jonathan Keenan; Kerstin de Wit Journal: Health Technol Assess Date: 2019-12 Impact factor: 4.014
Authors: Saleh Aloraibi; Vicky Booth; Katie Robinson; Eleanor Katharine Lunt; Deborah Godfrey; Alan Caswell; Margaret Kerr; Benjamin Ollivere; Adam Lee Gordon; J R F Gladman Journal: Age Ageing Date: 2021-06-28 Impact factor: 10.668
Authors: Daniel Horner; John W Stevens; Abdullah Pandor; Tim Nokes; Jonathan Keenan; Kerstin de Wit; Steve Goodacre Journal: J Thromb Haemost Date: 2019-12-01 Impact factor: 5.824